JAMA Clinical Reviews cover image

Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease

JAMA Clinical Reviews

00:00

The Clinical Meaningfulness of DINANIMAB

Nearly all of the primary and secondary outcomes showed statistically significant benefit of DINANIMAB. A question that comes up a lot is the differences may be statistically significant, but are they clinically meaningful? Can you talk a little bit about how clinicians and patients might think about the clinical meaningfulness of the findings based on this study?

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app